Atezolizumab and Its Many Uses

Atezolizumab is an immune-checkpoint inhibitor, which has been approved by the US Food and Drug Administration (FDA) in various combinations for a number of cancer types in recent years.

Source: CancerNetwork - August 23, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS, Mehmet Sitki Copur, MD, FACP Source Type: news